Isabelle Poizot-Martin Selected Research

N-acetoacetyl-N-deacetylcolchicine

1/2021	Determinants of Second Primary Cancer Type in Survivors of Virus-Related and Non-Virus-Related Cancer Living With HIV in the French Dat'AIDS Cohort.
1/2021	Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS Cohort.
9/2003	Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isabelle Poizot-Martin Research Topics

Disease

16	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 02/2002
15	HIV Infections (HIV Infection) 01/2020 - 09/2003
11	Infections 03/2022 - 11/2003
10	Neoplasms (Cancer) 02/2022 - 09/2003
6	Fibrosis (Cirrhosis) 01/2017 - 10/2011
5	Kaposi Sarcoma (Kaposi's Sarcoma) 03/2022 - 02/2002
5	Coinfection 01/2022 - 07/2014
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2014 - 09/2003
2	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 07/2011
2	Hepatitis C 12/2020 - 01/2016
2	Viremia 01/2020 - 09/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 06/2011
2	Anus Neoplasms (Anal Cancer) 11/2014 - 04/2009
2	Hepatitis B 10/2014 - 10/2011
2	Lipodystrophy 01/2011 - 01/2002
1	Opportunistic Infections (Opportunistic Infection) 02/2022
1	Immune Reconstitution Inflammatory Syndrome 02/2022
1	Vaccinia 01/2022
1	Fatty Liver 01/2021
1	Reinfection 01/2020
1	Immune System Diseases (Immune Disorders) 11/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Frailty 01/2017
1	Urticaria (Hives) 01/2017
1	Chronic Renal Insufficiency 01/2017
1	Osteoporosis 01/2017
1	Drug-Related Side Effects and Adverse Reactions 09/2016
1	Fatigue 09/2016
1	Papillomavirus Infections 05/2016
1	Anemia 01/2016
1	Chronic Hepatitis C 01/2015
1	Lung Neoplasms (Lung Cancer) 11/2014
1	Persistent Infection 11/2014
1	Skin Neoplasms (Skin Cancer) 11/2014
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2013
1	Liver Neoplasms (Liver Cancer) 06/2012
1	Hypertension (High Blood Pressure) 07/2011
1	Hepatitis 09/2010
1	Squamous Intraepithelial Lesions 04/2009
1	Lymphoma (Lymphomas) 02/2009
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2009
1	Liver Diseases (Liver Disease) 01/2009
1	Pain (Aches) 08/2007

Drug/Important Bio-Agent (IBA)

9	RNA (Ribonucleic Acid)IBA 01/2020 - 02/2009
7	Protease Inhibitors (Protease Inhibitor)IBA 03/2022 - 01/2002
7	Antiviral Agents (Antivirals)IBA 12/2020 - 01/2015
7	Ribavirin (Virazole)FDA LinkGeneric 01/2017 - 10/2013
5	Pharmaceutical PreparationsIBA 01/2022 - 11/2003
4	InterferonsIBA 09/2016 - 10/2013
3	VaccinesIBA 01/2022 - 09/2010
3	N-acetoacetyl-N-deacetylcolchicineIBA 01/2021 - 09/2003
3	Tenofovir (Viread)FDA Link 01/2019 - 09/2016
3	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 03/2016 - 11/2014
3	Interleukin-2 (IL2)IBA 10/2010 - 09/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2009
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2014
2	Emtricitabine (Emtriva)FDA Link 01/2019 - 09/2016
2	Peptide Hydrolases (Proteases)FDA Link 10/2018 - 11/2014
2	Reverse Transcriptase InhibitorsIBA 10/2018 - 01/2002
2	RacivirIBA 09/2016 - 01/2014
2	Ritonavir (Norvir)FDA Link 09/2016 - 01/2012
2	efavirenz (Sustiva)FDA Link 09/2016 - 01/2011
2	N- (8- aminohexyl)- 5- iodonaphthalene- 1- sulfonamide (W8)IBA 03/2016 - 01/2016
2	telaprevirIBA 01/2016 - 11/2014
2	NucleosidesIBA 01/2011 - 01/2002
1	GlucocorticoidsIBA 02/2022
1	LipopeptidesIBA 01/2022
1	Integrase InhibitorsIBA 01/2020
1	NivolumabIBA 01/2019
1	pembrolizumabIBA 01/2019
1	Immune Checkpoint InhibitorsIBA 01/2019
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2018
1	Lenalidomide (CC 5013)FDA Link 01/2017
1	Prostaglandins AIBA 01/2017
1	Atazanavir Sulfate (Reyataz)FDA Link 09/2016
1	Darunavir (Prezista)FDA Link 09/2016
1	Inosine TriphosphataseIBA 01/2016
1	Transaminases (Aminotransferases)IBA 09/2013
1	dolutegravirIBA 03/2013
1	Raltegravir Potassium FDA Link 03/2013
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2012
1	Immunoglobulin G (IgG)IBA 10/2011
1	Immunoglobulin M (IgM)IBA 10/2011
1	AntibodiesIBA 10/2011
1	Antineoplastic Agents (Antineoplastics)IBA 06/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	LipidsIBA 01/2011
1	HDL CholesterolIBA 01/2011
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 09/2010
1	Peptides (Polypeptides)IBA 09/2010
1	Opioid Analgesics (Opioids)IBA 11/2009

Therapy/Procedure

17	Therapeutics 03/2022 - 02/2009
12	Highly Active Antiretroviral Therapy (HAART) 01/2021 - 01/2002
5	Drug Therapy (Chemotherapy) 02/2022 - 09/2003
1	Art Therapy 02/2022
1	Immunotherapy 01/2019
1	Palliative Care (Palliative Therapy) 09/2016
1	Opiate Substitution Treatment 11/2009
1	Intramuscular Injections 08/2007